Todd DuChene, Chief Legal and Administrative Officer at Core Scientific, Inc. (NASDAQ:CORZ), has recently made significant stock transactions amid an impressive 347% rise in the company’s share price over the past year. On January 2nd and 3rd, DuChene sold a total of 132,810 shares of common stock, generating proceeds of approximately $1.89 million. The sale was made at prices ranging from $14.243 to $14.5682 per share, with shares currently trading at $15.38. InvestingPro analysis shows strong analyst confidence, with price targets ranging from $17 to $26.
These transactions were made to satisfy the tax obligations associated with the acquisition of restricted stock units. Following these sales, DuChene holds 2,048,700 shares of Core Scientific, demonstrating continued confidence in the company, which maintains healthy liquidity with a current ratio of 3.63. Additionally, on December 31, DuChene acquired 55,758 shares at no cost as part of a performance-based restricted stock vesting. InvestingPro subscribers can access 14 additional key insights into Core Scientific’s financial health and growth prospects through a comprehensive Pro Research Report.
In other recent news, Core Scientific, a digital infrastructure company, announced plans to offer a $500 million convertible senior bond, a financing strategy to convert investors’ debt into equity in the future. The move is seen as an attempt to secure additional funding through institutional channels. In response, Compass Point, a financial services firm, raised its price target on Core Scientific to $26.00 and maintained a Buy rating, citing the company’s potential to secure high-performance computing contracts and diversify its customer base.
In parallel, Core Scientific has started construction on a new 100-megawatt data center in Muskogee, Oklahoma, which should power CoreWeave NVIDIA (NASDAQ: ) GPUs for a confidential client. This development is part of a larger agreement with CoreWeave, which includes a total of 500 megawatts of IT load contracted for high-performance computing services hosting operations.
Meanwhile, Jefferies, a global investment banking firm, gave Core Scientific a ‘Buy’ rating, recognizing the company’s successful transition from mining to building AI-focused data centers. Other firms such as Canaccord Genuity and B.Riley also maintain a ‘Buy’ rating on Core Scientific, reflecting confidence in the company’s future prospects.
These recent developments underscore Core Scientific’s strategic moves to secure additional funding, expand its infrastructure and streamline its operations, garnering positive responses from several financial firms.
This article was generated with the support of artificial intelligence and reviewed by an editor. See our T&C for more information.
